Seattle Genetics reported $510.3M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US USD 14.81B 229M
Acadia Pharmaceuticals ACAD:US USD 130.71M 3.85M
Agios Pharmaceuticals AGIO:US USD 3.52M 2.07M
Amgen AMGN:US USD 6.84B 187M
Astellas Pharma 4503:JP JPY 380.39B 1.4B
Bayer BAYN:GR EUR 11.28B 1.54B
Biogen BIIB:US USD 2.51B 80.6M
Biomarin Pharmaceutical BMRN:US USD 505.34M 28.45M
Bluebird Bio BLUE:US USD 71K 1.45M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Celldex Therapeutics CLDX:US USD 407K 244K
Clovis Oncology CLVS:US USD 30.66M 1.48M
Daiichi Sankyo 4568:JP JPY 340.48B 13B
Eisai 4523:JP JPY 174.36B 9.9B
Eli Lilly And LLY:US USD 7.3B 360.2M
Esperion Therapeutics ESPR:US USD 18.98M 139K
Exelixis EXEL:US USD 411.74M 7.69M
Genmab GEN:DC DKK 4.09B 925M
Gilead Sciences GILD:US USD 7.39B 347M
GlaxoSmithKline GSK:LN GBP 7.38B 453M
Glaxosmithkline GSK:US GBP 7.38B 453M
Immunogen IMGN:US USD 15.38M 1.21M
Insmed INSM:US USD 67.73M 2.51M
Karyopharm Therapeutics KPTI:US USD 36.14M 3.53M
Macrogenics MGNX:US USD 41.73M 15.73M
Merk MRK:US USD 13.83B 1.13B
Mirati Therapeutics MRTX:US USD 5.43M 69K
Moderna Inc MRNA:US USD 3.36B 1.38B
Nektar Therapeutics NKTR:US USD 23.62M 2.04M
Novartis NOVN:VX USD 12.84B 243M
Pfizer PFE:US USD 24.29B 1.65B
Puma Biotechnology PBYI:US USD 57.1M 2.42M
Regeneron Pharmaceuticals REGN:US USD 3.41B 478.2M
Sarepta Therapeutics SRPT:US USD 230.27M 3.22M
Seattle Genetics SGEN:US USD 510.3M 12.8M
Takeda 4502:JP JPY 1.1T 94.24B
Teva Pharmaceutical TEVA:IT USD 3.6B 191M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M
Xencor XNCR:US USD 27.3M 2.88M
YTE INCY:US USD 823.3M 88.09M